Activity Description

In this infographic-based activity, an expert in chronic kidney disease (CKD) discusses anemia in CKD and explores the potential role of HIF-PH inhibitors in the treatment of this condition.

Target Audience

This activity has been designed to meet the educational needs of nephrologists, primary care physicians, medical and pharmacy directors, medical directors, pharmacy directors, formulary and P&T committee directors and other clinicians involved in the management of patients with anemia in CKD.

Educational Objectives

Upon completion of this activity, participants will be able to:

• Identify the epidemiology, pathology, and burden of anemia associated with CKD
• Discuss limitations of the current model of treatment for anemia associated with CKD
• Differentiate the mechanisms of action of current and emerging treatments for anemia associated with CKD
• Recognize the benefits and limitations of current and emerging agents to treat anemia in CKD

Providership, Credit, and Support

This CME/CPE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP in collaboration with FibroGen.

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The Medical Learning Institute, Inc. (MLI) designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0468-9999-20-022-H01-P
Type of Activity: Knowledge

Faculty Disclosures

Chair
Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN
Chief of Medicine
Professor of Medicine at UCSF
VA Hospital
Fresno, California

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AstraZeneca; CorMedix Inc; and Otsuka America Pharmaceutical, Inc.
Speakers Bureau participant with AstraZeneca and Janssen Pharmaceuticals, Inc.

Planning Committee Disclosures

Teresa Haile, RPh, MBA, Pharmacy Planner, MLI, has nothing to disclose.

The planners from Medical Learning Institute, Inc., the accredited provider, and PeerView Institute for Medical Education, the joint provider, do not have any financial relationships with an ACCME-defined commercial interest related to the content of this accredited activity during the past 12 months unless listed below.

Margery Tamas, Medical Director, PVI, discloses that she was a Consultant for Fresenius Medical Care North America.

Content/Peer Reviewer Disclosures

The following Content/Peer Reviewers have nothing to disclose:

Kaushal Patel, MD
Shelley Chun, PharmD

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this accredited activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you upon completion. You will receive your certificate from email@email.peerviewpress.com. If you have questions regarding the receipt of your emailed certificate, please contact via email at info@PeerView.com.

For Pharmacists: Upon receipt of the completed activity evaluation form, you will receive an email from email@email.peerviewpress.com within 2 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service. MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and date of birth. Within 6 weeks, view your participation record at the NABP website: mycpemonitor.net.

About This CME/CPE Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

Copyright © 2000-2020, PeerView